- Jul 2018
-
europepmc.org europepmc.org
-
On 2017 Dec 15, Franz Schelling commented:
Is it allowed to remind this fact: An improved lesion detection cannot make do for a clear lesion identification: T2 hyperintense ovoid areas can hardly be regarded as a hallmark of a particular pathology. It is quite sobering besides if brain loss and (a growth in) T2 lesion volume and counts must be viewed to as the clinical MS trials' typical imaging endpoints.
This comment, imported by Hypothesis from PubMed Commons, is licensed under CC BY.
-
- Feb 2018
-
europepmc.org europepmc.org
-
On 2017 Dec 15, Franz Schelling commented:
Is it allowed to remind this fact: An improved lesion detection cannot make do for a clear lesion identification: T2 hyperintense ovoid areas can hardly be regarded as a hallmark of a particular pathology. It is quite sobering besides if brain loss and (a growth in) T2 lesion volume and counts must be viewed to as the clinical MS trials' typical imaging endpoints.
This comment, imported by Hypothesis from PubMed Commons, is licensed under CC BY.
-